Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications

Human Gene Therapy

Volumn 12, Issue 1, 2001, Pages 13-23

  Paquin, André ^a   Jaalouk, Diana E ^a   Galipeau, Jacques ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; THYMIDINE KINASE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN TARGETING; REPORTER GENE; SUICIDE GENE; T LYMPHOCYTE; TRANSGENE; TUMOR REGRESSION; VIRUS GENOME;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; RNA, MESSENGER; SIMPLEXVIRUS; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0035163821     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401450924     Document Type: Article

References (40)

1. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells
2. Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances pro-drug and radiation sensitivity
3. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
4. Transfer of the HSVtk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation
5. Cell therapy: Achievements and perspectives
6. Tolerance induced without immunosuppression in a T-lymphocyte suicide-gene therapy cardiac allograft model in mice
7. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
8. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-betal
9. Suicide gene-mediated modulation of graft-versus-host disease
10. A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins
11. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: Molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK
12. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs
13. Vesicular stomatitis virus G pseudo-typed retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer
14. CD4(+) T helper cells engineered to produce latent TGFbetal reverse allergen-induced airway hyperreactivity and inflammation
15. Re-examination and further development of a precise and rapid dye method for measuring cel growth/cell kill
16. Versatile retroviral vectors for potential use in gene therapy
17. Adoptive cellular therapy
18. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells
19. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy
20. Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity
21. Macaque lymphocytes transduced by a constitutively expressed interferon beta gene display an enhanced resistance to SIVmac251 infection
22. Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease
23. Antiviral activity and mechanism of action of ganciclovir
24. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer
25. Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein
26. Mammary tumorigenesis in chemical carcinogentreated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice
27. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors
28. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector
29. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
30. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
31. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells
32. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
33. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals
34. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity
35. The application of gene therapy in autoimmune diseases
36. Kinetic parameters and growth curves for experimental tumor systems. Part 1
37. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24
38. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors
39. A retroviral vector system "STITCH" in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes
40. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-I RNA